Eventide Asset Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 369 filers reported holding REPLIGEN CORP in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$18,922,190
+12.4%
119,0000.0%0.34%
+19.3%
Q2 2023$16,833,740
-16.0%
119,0000.0%0.28%
-22.6%
Q1 2023$20,034,840
-0.6%
119,0000.0%0.37%
-7.3%
Q4 2022$20,147,890
-9.5%
119,0000.0%0.40%
-9.4%
Q3 2022$22,266,000
+15.2%
119,0000.0%0.44%
+6.1%
Q2 2022$19,326,000
-13.7%
119,0000.0%0.41%
+17.7%
Q1 2022$22,383,000
-29.0%
119,0000.0%0.35%
-12.9%
Q4 2021$31,516,000
-8.4%
119,0000.0%0.40%
-11.0%
Q3 2021$34,390,000
+44.8%
119,0000.0%0.45%
+42.0%
Q2 2021$23,755,000
+2.7%
119,0000.0%0.32%
-7.0%
Q1 2021$23,135,000
+1.5%
119,0000.0%0.34%
-2.0%
Q4 2020$22,804,000
+29.9%
119,0000.0%0.35%
+1.7%
Q3 2020$17,557,000
+19.4%
119,0000.0%0.34%
+7.5%
Q2 2020$14,710,000
+28.0%
119,0000.0%0.32%
-14.0%
Q1 2020$11,488,000
+4.4%
119,0000.0%0.37%
+20.0%
Q4 2019$11,008,000
+20.6%
119,0000.0%0.31%
+2.6%
Q3 2019$9,126,000
-37.2%
119,000
-29.6%
0.30%
-31.7%
Q2 2019$14,526,000
+123.5%
169,000
+53.6%
0.44%
+97.3%
Q1 2019$6,499,000
+12.0%
110,0000.0%0.22%
-12.8%
Q4 2018$5,801,000
-4.9%
110,0000.0%0.26%
+14.7%
Q3 2018$6,101,000
+17.9%
110,0000.0%0.22%
+4.2%
Q2 2018$5,174,000
+30.0%
110,0000.0%0.22%
+15.6%
Q1 2018$3,980,000
-0.3%
110,0000.0%0.19%
-10.6%
Q4 2017$3,991,000
-5.3%
110,0000.0%0.21%
-13.0%
Q3 2017$4,215,000
-7.5%
110,0000.0%0.24%
-15.8%
Q2 2017$4,558,000
+17.7%
110,0000.0%0.28%
+10.9%
Q1 2017$3,872,000
+14.2%
110,0000.0%0.26%
+15.8%
Q4 2016$3,390,000
+2.1%
110,0000.0%0.22%
+8.9%
Q3 2016$3,321,000
+10.3%
110,0000.0%0.20%
+10.3%
Q2 2016$3,010,000
+2.0%
110,0000.0%0.18%
+11.5%
Q1 2016$2,950,000
-48.4%
110,000
-45.5%
0.16%
-42.3%
Q4 2015$5,715,000
+15.0%
202,000
+13.2%
0.29%
-1.0%
Q3 2015$4,968,000
+21.1%
178,400
+79.5%
0.29%
+30.2%
Q2 2015$4,102,000
+35.9%
99,4000.0%0.22%
-2.2%
Q1 2015$3,018,000
+53.4%
99,4000.0%0.23%
+5.6%
Q4 2014$1,968,000
-0.6%
99,4000.0%0.22%
-22.1%
Q3 2014$1,979,000
-12.6%
99,4000.0%0.28%
-10.4%
Q2 2014$2,265,000
+227.8%
99,400
+85.1%
0.31%
+187.9%
Q1 2014$691,000
-5.6%
53,7000.0%0.11%
-52.7%
Q4 2013$732,00053,7000.23%
Other shareholders
REPLIGEN CORP shareholders Q2 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders